Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adobe Systems Inc (ADBE) vs Dolby Laboratories, Inc. (DLB) Price & Performance

Adobe Systems Inc
Dolby Laboratories, Inc.

Price performance

Price movement over the last 24 hours

Key statistics

Adobe Systems Inc vs Dolby Laboratories, Inc. — how do they compare? Adobe Systems Inc trades at $220.34 (market cap $88.06B), while Dolby Laboratories, Inc. trades at $50.38 (market cap $4.66B). The key difference: Adobe Systems Inc is far larger — about 18.9× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.86% dividend while Adobe Systems Inc pays none. Which is the better fit depends on your goals.

ADBEDLB
Market Cap
$88.06B$4.66B
Volume
5,187,646
Sector
TechnologyIndustrials
52-Week High
$382.24$76.79
52-Week Low
$193.41$49.31
Enterprise Value
$89.50B$4.12B
Dividend Yield
2.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adobe Systems Inc

Adobe (ADBE) trades at $219.75, up 0.77% with strong fundamentals including 29.99% net margin and consistent earnings beats. The stock shows bullish technical signals despite recent volatility, with support at $218 and resistance at $228. Revenue growth accelerated to $23.77B in 2025, while institutional activity remains mixed amid AI competition concerns.

ADBE presents a compelling value opportunity with a 12.67 P/E ratio and 49% analyst buy ratings, though AI disruption fears and CEO transition create near-term uncertainty. The consensus price target of $246.75 implies 12% upside potential, balanced against sector-wide software pressures.

Dolby Laboratories, Inc.

DLB trades at $49.31, down 3.6% today, with technical indicators showing bearish momentum. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.37 versus $1.31 expected. Revenue remains stable at $1.35B for 2025, with robust gross margins of 87.44%. Recent developments include FDA progress for zervimesine in DLB psychosis and recognition as GM's 2025 Supplier of the Year.

Despite near-term technical weakness, DLB's patent-protected revenue streams and high profitability support long-term value. The consensus price target of $87.50 implies significant upside, but investors face risks from cyclical end-markets and potential dilution from drug development. The stock presents a contrarian opportunity with 47% analyst buy ratings amid current bearish sentiment.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adobe Systems Inc

Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.

Read more on ADBE

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB